A group of 20 early-stage life sciences startups in Washington each received $25,000 grants, part of an effort to fuel the “next generation” of life science innovation in the state.… Read More
Phenome Health, a Seattle research organization dedicated to what it calls a data-driven approach to human health and longevity, launched a partnership Wednesday with the Buck Institute for Research on… Read More
First Lady Jill Biden visited Fred Hutchinson Cancer Center on Friday in Seattle, where she met with researchers and spoke about cancer prevention and the need to mitigate side effects… Read More
Italian-born neuroscientist Vittorio Gallo first got interested in research through his appreciation of art, which made him wonder how our brains process colors, forms and compositions. That curiosity launched Gallo… Read More
A Seattle-area tech company has reason to smile after receiving clearance from the Food and Drug Administration for its tooth-tapping device and machine learning platform that helps dental professionals detect… Read More
Plenty of high school students plan to make careers out of coding when they graduate from college. And plenty of other students are probably planning careers as cancer-research scientists. But… Read More
Twenty years after Microsoft co-founder Paul Allen created the bioscience research center that bears his name, Seattle’s Allen Institute is still pushing out into new frontiers. But this weekend, the… Read More
Notch Therapeutics announced that it will shut down its lab in Vancouver, B.C., and lay off about 25 employees, with some offered relocation options. Editor’s note: Story updated with more details… Read More
Seattle-area health tech startup Viome Life Sciences closed a $86.5 million Series C round and announced a deal with CVS to sell its gut microbiome test in 200 CVS locations… Read More
Cocrystal Pharma, a Seattle-area company co-founded by a Nobel Prize winner and backed by biotech veterans, is taking aim at high-profile viruses. The publicly traded company has the green light… Read More
Seattle startup Phase Genomics will develop its platform to detect chromosomal aberrations in cancer with $2.5 million in new funding. The project is fueled with a $2 million small business… Read More
The Access to Advanced Health Institute will develop an RNA vaccine against the chikungunya virus with a fresh $18 million award from the U.S. National Institutes of Health. Chikungunya is… Read More
A new science cluster is growing in Seattle. The two 15-story towers of Dexter Yard, with 528,000 square feet of office and lab space, are starting to fill up with… Read More
Amazon announced Tuesday that it is expanding its Amazon Clinic virtual health care service to all 50 states and Washington, D.C., to help more customers get treatment for a variety… Read More
Seattle startup Proprio raised a $43 million Series B round following FDA clearance for its surgical navigation platform that allows clinicians to see key structures on a screen in three… Read More
After announcing in March that it was seeking “strategic alternatives” for its future, Seattle publicly-traded biotechnology company Neoleukin Therapeutics is now planning to merge with New York City-based Neurogene, a… Read More
CurvaFix, a Seattle-area startup that makes implants to repair fractures in curved bones, raised $39 million. The six-year old company’s flagship product is an implant to repair pelvic fractures. The… Read More
EchoNous, a startup that markets a compact, AI-powered ultrasound device, raised $7 million. The funding was noted in a SEC filing and confirmed by a company spokesperson.
University of Washington spinout Wavely Diagnostics, which is developing a smartphone app to detect ear infections, raised $1.35 million. The Seattle company’s diagnostic app uses acoustic signals to detect signs of an… Read More
We’re inside the headquarters of Outpace Bio in Seattle. Senior scientist Bobby Langan shows a video of one of his favorite deep-learning tools, used to create experimental cancer therapeutics. A… Read More
Just – Evotec Biologics won a contract from the U.S. Department of Defense worth up to $75 million to develop drug candidates for orthopoxviruses, the group of viruses that cause… Read More
Morphimmune, a biotech company led by former Seagen CEO Clay Siegall, is merging with a public biotech company, Immunome, in a deal boosted with $125 million from private investors. Siegall… Read More
Seattle-based startup Heard, which supports mental health professionals with financial software and services, raised $15 million in new funding. Heard offers booking, payroll and tax workflow products. Solo practitioners can… Read More
University of Washington spinout AltPep, which is developing tests and treatments for Alzheimer’s and Parkinson’s disease, completed a $52.9 million Series B funding round. The funding will help propel the… Read More
CTI BioPharma, a Seattle-based publicly traded biotech company developing therapies for blood-related cancers, is set to be acquired in a deal with Swedish biotech giant Sobi. The acquisition, announced Wednesday,… Read More
Seattle Children’s researcher Jim Olson has some thoughts about how to go about launching and leading a biotech startup. His research lab has helped forge Seattle-area startups developing a wide… Read More
Amid a tightened fundraising environment, life sciences companies should double down on basics like focusing on key projects and getting out data, and look at creative ways to raise capital.… Read More
Washington state lawmakers recently extended a law that loosens restrictions on audio-only healthcare delivery, while they wait for the results of a study evaluating its effects. Early in the pandemic,… Read More
Biomedicine pioneer Leroy Hood says that artificial intelligence will play a key role in the future of healthcare by accelerating the progress of “scientific wellness,” an approach that he has… Read More
